Importantly, hsa-miR-193b-3p, which targeted 59 DEGs (eg., NCAPG), and hsa-miR-148a-3p, which targeted 15 DEGs (eg., MYC), were highlighted in the DE-miRNA–DEG regulatory network; additionally, hsa-miR-1179, which targeted KNL1, was newly predicted to be associated with GC. The gene discussed is KNL1; the disease is gastric cancer.